Watch Dr Gordon Rustin - Mount Vernon Cancer Center, UK, Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer on ecancer tv. Cancer journal: online canc
advertisement
related videos
tags
collected by 1 person
details
- Blog
- Geek Blog
- Vodpod on Twitter
- Jobs
About Us
- Publishing
- Collecting
- Discovery
- VodSpot
- Widgets
- API
Features
- Forums
- Help
- Vodpod Button
Support
Copyright © 2009 Remixation, Inc.
All Rights Reserved
Gordon Rustin, MD, Mount Vernon Cancer Center, Hertfordshire, United Kingdom, speaking at ASCO 2009: Treatment Based on Rising CA125 Blood Levels Does Not Improve Survival for Recurrent Ovarian Cancer, Compared to Waiting for Symptoms to Arise: European researchers report that starting treatment early for an ovarian cancer relapse based on CA125 blood levels alone does not improve overall survival, compared with delaying treatment until symptoms arise. 07 Mar. 09